In addition, CB2 exerts an inhibitory effect on inflammatory processes [55], including macrophage migration [56], and provides an important therapeutic target for reducing/ablating some immunopathological processes associated with HIV-1 infection [56], a beneficial effect confirmed by the observation that CBR2 agonists reduce AIDS symptoms [57]. Here, CNR2 is linked to HIV-1 infection.